Clinical Trials Directory

Trials / Terminated

TerminatedNCT02797405

Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay

Evaluation of Individual Radiosensitivity of Cancer Patients to be Treated by Radiotherapy or Radiochemotherapy Per-operative

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
97 (actual)
Sponsor
Centre Leon Berard · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

THEODORA is a prospective pilot clinical trial aiming at first to evaluate and validate the predictive value of the A \& MS bioassays on tumor control by radiotherapy.

Detailed description

For that purpose, this project is composed of 3 stages: * A Calibration stage that will allow to evaluate the correlation between the clinical tumor response parameters (i.e. TV/AP features) and the radiobiological parameters issued from the A/MS bioassays in order to develop a mathematic model defining the UTCR parameter * A Validation stage in order to assess the validity of A/MS bioassays towards clinical tumour response parameters (i.e. both TV/AP features and UTCR). * A Precision stage will be performed either to improve the precision of the predictive performance of the A and MS bioassays or to establish a new mathematical model describing the correlation between clinical and radiobiological parameters. The objective of this precision stage will depend of the results of the calibration stage (see below). This prospective clinical study will be conducted in a population of patients with different tumor types in order to explore a large range of tumor radiosensitivity including sarcomas, rectal carcinoma and esophagus tumor.

Conditions

Interventions

TypeNameDescription
RADIATIONStandard treatmentSarcoma patients will undergo radiotherapy followed by surgery Rectum cancer patients will undergo radio-chemotherapy followed by surgery Esophagus cancer patients will undergo radio-chemotherapy followed by surgery

Timeline

Start date
2016-10-01
Primary completion
2019-08-13
Completion
2020-03-13
First posted
2016-06-13
Last updated
2020-03-25

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02797405. Inclusion in this directory is not an endorsement.